查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016474

旅行疫苗市場報告：組成、疾病和地區（2026-2034 年）

Travel Vaccines Market Report by Composition, Disease, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球旅行疫苗市場規模達49億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到105億美元，2026年至2034年的複合年成長率（CAGR）為8.63%。該市場正穩步成長，其促進因素包括：人們對異國風情和偏遠地區旅行體驗的需求不斷成長；政府為保障公民健康而推行的免費旅行疫苗接種計劃；以及疾病模式的演變和新威脅的出現。

旅行疫苗市場趨勢：

國際旅行增加

全球公眾國際旅行的增加正在推動市場成長。隨著全球化和旅行便利性的提高，人們在全球範圍內感染疾病的風險也隨之增加。由於旅行者前往的目的地醫療水平和疾病爆發情況各不相同，接種疫苗已成為一項必不可少的預防措施。休閒旅行、商務旅行和國際學生出國留學人數的成長進一步推動了這一趨勢。此外，人們對異國風情或偏遠地區旅行體驗的日益成長的需求意味著他們正在探索具有獨特健康風險的地區，這凸顯了對特定疫苗的需求。個人旅行健康防範意識的提高，凸顯了疫苗對國際旅客的重要性，為市場帶來了良好的前景。

政府措施和法規

政府的措施和法規在推動市場發展方面發揮著至關重要的作用。許多國家都認知到保護公眾健康和防止疾病透過國際旅行傳播的重要性。因此，一些國家的政府機構實施了關於旅行疫苗接種的嚴格法規和建議。這些法規通常要求旅客在出入境時接種特定疫苗，特別是前往已知疾病風險地區的旅客。世界衛生組織（世衛組織）的《國際衛生條例》（IHR）要求前往某些國家的旅客出示黃熱病疫苗接種證明。此外，一些政府也為本國公民提供旅行疫苗津貼或免費接種，作為其公共衛生計畫的一部分。這些法規和措施不僅為旅客設定了法律要求，還提高了公眾對旅行疫苗必要性的認知，並推動了市場需求。

全球感染疾病爆發與大流行

全球感染疾病爆發和疫情對市場成長有重大影響。這些事件凸顯了國際旅行可能帶來的健康風險，並促使旅客和各國政府提高警覺。為因應這些疫情，人們對能夠預防特定地區流行感染疾病的疫苗的需求日益成長。感染疾病爆發和疫情促使人們研發和分發疫苗，以遏止病毒傳播，並保障旅行安全。旅行者越來越意識到接種疫苗以保護自身和他人的必要性，從而提高了旅行疫苗的使用率。各國政府和世界衛生組織也強調疫苗作為預防和控制感染疾病爆發的重要手段，並建議旅客在出發前先接種疫苗。

疾病格局的變化與新出現的威脅

疾病模式的動態變化和新型感染疾病威脅的出現正在推動市場成長。感染疾病並非一成不變，它們會不斷演變、變異並傳播到新的地區。這種不斷變化的情況要求我們持續研發疫苗，以對抗不斷演變的病原體。近年來，茲卡病毒和伊波拉等疾病已成為旅客關注的焦點，促使人們研發針對這些威脅的特異性疫苗。人們對不斷變化的疾病情況的認知不斷提高，加上資訊獲取管道的日益便捷，促使人們在出行前接種疫苗以保護自身健康。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球旅行疫苗市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：按組件
  • 市場區隔：依疾病分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依構成

  • 單一成分疫苗
  • 聯合疫苗

第7章 市場區隔：依疾病分類

  • 甲型肝炎
  • DPT
  • 黃熱病
  • 傷寒
  • B型肝炎
  • 麻疹和腮腺炎
  • 狂犬病
  • 腦膜炎奈瑟菌
  • 水痘
  • 日本腦炎
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第9章 SWOT 分析

第10章：價值鏈分析

  • 探勘階段
  • 臨床前和臨床開發
  • 獲得監管機構的核准
  • 製造業
  • 行銷和分銷

第11章：波特五力分析

第12章：價格分析

第13章：旅行疫苗生產流程

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott
    • Bavarian Nordic A/S
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Sanofi SA
    • Valneva SE
Product Code: SR112026A1155

The global travel vaccines market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.63% during 2026-2034. The market is experiencing steady growth driven by the escalating demand for exotic and off-the-beaten-path travel experiences, government initiatives to provide free travel vaccinations to their citizens as part of public health programs, and changing disease patterns and emerging threats.

Travel Vaccines Market Analysis:

  • Market Growth and Size: The market is witnessing strong growth, which can be attributed to increasing international travel activities. In addition, the rising awareness among the masses about travel-related diseases is bolstering the market growth.
  • Technological Advancements: Innovations in vaccine development, such as the introduction of more convenient and effective formulations, is ensuring better protection for travelers.
  • Industry Applications: Travel vaccines are crucial for both leisure and business travelers, as they offer protection against various diseases.
  • Geographical Trends: North America leads the market, on account of its strong emphasis on health and safety during travel. However, Europe is emerging as a fast-growing market, driven by its diverse range of destinations and a large number of international travelers.
  • Competitive Landscape: Key players in the market are actively engaged in strategic initiatives. They are investing in research and development (R&D) activities to expand their vaccine portfolios, addressing emerging travel-related health risks, and enhancing existing efficacy of vaccines.
  • Challenges and Opportunities: While the market faces challenges, such as vaccine hesitancy and regulatory hurdles, it also encounters opportunities in expanding vaccine accessibility and tailored vaccine solutions for specific regions.
  • Future Outlook: The future of the travel vaccines market looks promising, with ongoing research and development (R&D) activities in vaccine production. Moreover, the adoption of digital health solutions for pre-travel consultations is expected to propel the growth of the market.

Travel Vaccines Market Trends:

Rising international travel

The increasing international travel among the masses around the world is supporting the growth of the market. As globalization and accessibility to travel are growing, the risk of exposure to infectious diseases in various parts of the world is rising. Travelers are venturing to destinations with varying healthcare standards and disease prevalence, making vaccinations a crucial precaution. This trend is further bolstered by the growth of leisure travel, business travel, and international students studying abroad. Moreover, the desire for exotic and off-the-beaten-path travel experiences is leading individuals to explore regions with unique health risks, emphasizing the need for specialized vaccines. The growing awareness among individuals about health precautions while traveling is underscoring the importance of vaccines for international travelers, which is offering a favorable market outlook.

Government initiatives and regulations

Government initiatives and regulations play a pivotal role in driving the market. Many countries are recognizing the importance of safeguarding public health and preventing the spread of diseases through international travel. As a result, governing agencies of several countries are implementing stringent regulations and recommendations regarding travel vaccinations. These regulations often mandate certain vaccinations for travelers entering or exiting their borders, especially for destinations with known disease risks. The International Health Regulations (IHR) by the World Health Organization (WHO) require proof of yellow fever vaccination for travelers visiting certain countries. Additionally, some governments offer subsidized or free travel vaccinations to their citizens as part of public health programs. These regulations and initiatives not only create a legal requirement for travelers but also raise awareness about the necessity of travel vaccines, driving demand in the market.

Global disease outbreaks and pandemics

Global disease outbreaks and pandemics have a profound impact on driving the market. These events are encouraging travelers and governments, highlighting the potential health risks associated with international travel. In response to such outbreaks, there is an escalating demand for vaccines that can protect against specific infectious diseases prevalent in certain regions. Disease outbreaks and pandemics are leading to the development and distribution of vaccines to mitigate the spread of the virus and facilitate safe travel. Travelers are becoming more conscious about the need for vaccinations to protect themselves and others, leading to greater adoption of travel vaccines. Governments and international health organizations also emphasize the importance of vaccines as a key tool in preventing and controlling outbreaks, encouraging travelers to be vaccinated before embarking on their journeys.

Changing disease patterns and emerging threats

The dynamic nature of disease patterns and the emergence of new infectious threats are strengthening the growth of the market. Infectious diseases are not static, they evolve, mutate, and spread to new regions. This ever-changing landscape necessitates ongoing research and development (R&D) activities of vaccines to combat evolving pathogens. Diseases like Zika virus and Ebola are emerging as significant concerns for travelers in recent years, prompting the development of specific vaccines to address these threats. This awareness of changing disease patterns, along with the ease of accessing information, is encouraging individuals to seek protection through vaccinations before embarking on their journeys.

Travel Vaccines Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2026-2034. Our report has categorized the market based on composition and disease.

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines

Combination vaccines account for the majority of the market share

Combination vaccines offer the convenience of protecting against multiple diseases with a single injection. Popular combination vaccines include those that guard against hepatitis A and B, as well as typhoid. The primary advantage of combination vaccines is their efficiency in providing comprehensive protection, simplifying the vaccination process for travelers. This convenience is especially appealing to individuals who plan to visit regions with multiple disease risks, reducing the number of shots required. The combination vaccines segment is growing due to increased demand for streamlined vaccination regimens and improved compliance among travelers seeking a one-shot solution for their health needs.

Mono vaccines consist of individual vaccines targeting specific diseases. These vaccines are designed to provide protection against a single infectious agent, such as hepatitis A, hepatitis B, or typhoid. Mono vaccines are often recommended when travelers are visiting regions with a particularly high risk of one specific disease. They offer the advantage of targeted protection, allowing travelers to customize their vaccination regimen based on their destination and individual health needs.

Breakup by Disease:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Hepatitis A represents the leading market segment

Hepatitis A is a highly contagious viral infection that can be contracted through contaminated food or water, making it a significant concern for travelers. This segment includes vaccines that provide immunity against the hepatitis A virus. Due to its prevalence in many travel destinations, hepatitis A vaccination is recommended for individuals traveling to regions with inadequate sanitation and hygiene standards. The prominence of hepatitis A in the market reflects the widespread recognition of its risk and the importance of vaccination for the health and safety of travelers.

DPT vaccines, which protect against diphtheria, pertussis (whooping cough), and tetanus, are another important segment in the travel vaccines market. While these diseases are not exclusive to travel-related risks, they are included in some international vaccination recommendations. Tetanus can be a concern if travelers are exposed to contaminated wounds during their journeys. Therefore, DPT vaccines are essential for ensuring comprehensive protection against these preventable diseases, even when traveling.

Yellow fever vaccines target the prevention of yellow fever, a mosquito-borne viral disease prevalent in certain tropical regions. Travelers visiting countries in Africa and South America where yellow fever is endemic often require proof of vaccination for entry. The yellow fever segment in the travel vaccines market serves travelers who plan to explore these high-risk areas and need to adhere to international health regulations.

Typhoid vaccines are essential for travelers heading to regions with a higher risk of typhoid fever, often linked to contaminated food and water sources. These vaccines protect against Salmonella typhi, the bacterium responsible for typhoid fever. The typhoid segment addresses the specific health needs of travelers venturing to areas with suboptimal sanitation and hygiene conditions.

Hepatitis B vaccines are important for travelers who may engage in activities that carry an elevated risk of exposure to the hepatitis B virus, such as unprotected sexual contact or medical procedures involving needles. While hepatitis B is not exclusive to travel, these vaccines cater to the needs of individuals seeking protection against this virus while away from their home country.

Breakup by Region:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America

North America leads the market, accounting for the largest travel vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share due to the high level of outbound international travel from the United States and Canada. The region has a strong emphasis on health and safety during travel, and travelers are well-informed about the importance of vaccinations. Additionally, government recommendations and regulations, including those set by the Centers for Disease Control and Prevention (CDC) in the United States, play a significant role in promoting the uptake of travel vaccines. North America also benefits from a well-established healthcare infrastructure and a robust pharmaceutical industry, making travel vaccines readily accessible to the population.

Europe is another substantial market for travel vaccines. With its diverse range of destinations and a large number of international travelers, European countries have a strong demand for travel vaccinations. The European Union is establishing guidelines for travelers, recommending vaccinations based on destination and health history. European travelers tend to be proactive in seeking pre-travel healthcare advice, contributing to the growth of the market in the region.

The Asia Pacific region is experiencing rapid growth in the market due to a rise in outbound tourism and business travel. As economies in the region are expanding, more individuals have the means and desire to explore international destinations. This is resulting in a heightened awareness of travel-related health risks, catalyzing the demand for travel vaccines. Moreover, some countries are becoming popular tourist destinations, leading to an increase in inbound travelers who also require vaccinations.

The Middle East and Africa region also contribute to the market. This segment is driven by both outbound tourism and inbound travelers, as the region hosts various cultural, religious, and business events. Vaccinations are often mandated for individuals traveling to Mecca for Hajj or Umrah, further propelling the market growth. In addition, the presence of diseases like yellow fever and malaria underscores the importance of vaccinations for travelers.

Latin America is another growing market for travel vaccines, driven by increasing outbound travel from countries like Brazil and Mexico. Travelers from these regions often explore destinations within South America, North America, and Europe, necessitating vaccinations for disease prevention.

Leading Key Players in the Travel Vaccines Industry:

Key players in the market are actively engaged in several strategic initiatives. They are investing in research and development (R&D) activities to expand their vaccine portfolios, addressing emerging travel-related health risks and enhancing existing efficacy of vaccines. These companies are also focusing on increasing their global distribution networks to ensure accessibility to travel vaccines in diverse regions. Furthermore, they collaborate with healthcare providers, government agencies, and international health organizations to promote vaccination awareness and education among travelers. Additionally, pharmaceutical firms are exploring innovative vaccine delivery methods, such as oral or patch-based vaccines, to improve convenience and compliance for travelers. Overall, key players are dedicated to advancing the field of travel vaccines to meet the evolving needs of global travelers effectively.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided.

Some of the key players in the market include:

GlaxoSmithKline Pharmaceuticals Limited

  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abello A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.

Key Questions Answered in This Report

1. What is the size of the global travel vaccines market in 2025?

2. What is the expected growth rate of the global travel vaccines market during 2026-2034?

3. What are the key factors driving the global travel vaccines market?

4. What has been the impact of COVID-19 on the global travel vaccines market?

5. What is the breakup of the global travel vaccines market based on the composition?

6. What is the breakup of the global travel vaccines market based on the disease?

7. What are the key regions in the global travel vaccines market?

8. Who are the key companies/players in the global travel vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Travel Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Composition
  • 5.5 Market Breakup by Disease
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Composition

  • 6.1 Mono Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease

  • 7.1 Hepatitis A
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DPT
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Yellow Fever
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Typhoid
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Hepatitis B
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Measles and Mumps
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Rabies
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Meningococcal
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Varicella
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Japanese Encephalitis
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.12.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Travel Vaccines Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Travel Vaccines Industry: Value Chain Analysis

  • 10.1 Exploratory Stage
  • 10.2 Preclinical and Clinical Development
  • 10.3 Regulatory Approval
  • 10.4 Manufacturing
  • 10.5 Marketing and Distribution

11 Global Travel Vaccines Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Travel Vaccines Industry: Price Analysis

13 Travel Vaccines Manufacturing Process

  • 13.1 Product Overview
  • 13.2 Raw Material Requirements
  • 13.3 Manufacturing Process
  • 13.4 Key Success and Risk Factors

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott
    • 14.3.2 Bavarian Nordic A/S
    • 14.3.3 GlaxoSmithKline plc
    • 14.3.4 Pfizer Inc.
    • 14.3.5 Sanofi S.A.
    • 14.3.6 Valneva SE

List of Figures

  • Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2025
  • Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2025
  • Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
  • Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
  • Figure 9: Global: Travel Vaccines Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Travel Vaccines (DPT) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Travel Vaccines (DPT) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Travel Vaccines (Measles and Mumps) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Travel Vaccines (Measles and Mumps) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Travel Vaccines (Varicella) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Travel Vaccines (Varicella) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Travel Vaccines (Japanese Encephalitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Travel Vaccines (Japanese Encephalitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Travel Vaccines (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: Travel Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: Travel Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Europe: Travel Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Europe: Travel Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Asia Pacific: Travel Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Latin America: Travel Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Travel Vaccines Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million USD), 2026-2034
  • Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million USD), 2026-2034
  • Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Travel Vaccines: Raw Material Requirements
  • Table 6: Global: Travel Vaccines Market Structure
  • Table 7: Global: Travel Vaccines Market: Key Players